APA (7th ed.) Citation

Eggington, S., Tappenden, P., Pandor, A., Paisley, S., Saunders, M., Seymour, M., . . . Chilcott, J. (2006). Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer. British Journal of Cancer, 95(9), 1195. https://doi.org/10.1038/sj.bjc.6603348

Chicago Style (17th ed.) Citation

Eggington, S., P. Tappenden, A. Pandor, S. Paisley, M. Saunders, M. Seymour, P. Sutcliffe, and J. Chilcott. "Cost-effectiveness of Oxaliplatin and Capecitabine in the Adjuvant Treatment of Stage III Colon Cancer." British Journal of Cancer 95, no. 9 (2006): 1195. https://doi.org/10.1038/sj.bjc.6603348.

MLA (9th ed.) Citation

Eggington, S., et al. "Cost-effectiveness of Oxaliplatin and Capecitabine in the Adjuvant Treatment of Stage III Colon Cancer." British Journal of Cancer, vol. 95, no. 9, 2006, p. 1195, https://doi.org/10.1038/sj.bjc.6603348.